PROGRAM DIRECTOR John B. Gordon, MD, FACC

17TH ANNUAL MAUI CARDIOVASCULAR SYMPOSIUM FACULTY

S E V E N T E E N T H ANNUAL

Robert Adamson, MD, FACS

Surgical Director, Cardiac Transplant Program

Sharp Memorial Hospital, San Diego, CA

Charles Athill, MD, FACC

Electrophysiologist, San Diego Cardiac Center

Chief of Cardiology and Director of Electrophysiology

Sharp Memorial Hospital, San Diego, CA

Ralph Brindis, MD, MPH, MACC

Professor, Philip R. Lee Institute of Health

Policy Studies, UCSF, San Francisco, CA

Matthew Budoff, MD, FACC

Professor of Medicine, David Geffen School of Medicine

at UCLA Program Director and Director of Cardiac CT,

Division of Cardiology, Harbor-UCLA Medical Center

Torrance, CA

Jane C. Burns, MD

Director, Kawasaki Research Center

Professor of Pediatrics

UCSD/Rady Children’s Hospital

San Diego, CA

Robert Gillespie, MD, FACC

Director of Nuclear Cardiology

Sharp Rees-Stealy Medical Group

Sharp Memorial Hospital, San Diego, CA

Tim Henry, MD, FACC

Director of Cardiology

Cedars-Sinai Heart Institute

Los Angeles, CA

Dipti Itchhaporia, MD, FACC

Robert and Georgia Roth Chair for Excellence in Cardiac

Care and Director of Disease Management

Hoag Memorial Hospital Presbyterian

Newport Beach, CA

Brian Jaski, MD, FACC

Interventional Cardiologist

San Diego Cardiac Center Medical Director of Advanced Heart Failure and

Cardiac Transplant Program

Sharp Memorial Hospital, San Diego, CA

David Krummen, MD, FACC, FHRS

Director of Electrophysiology at VA Medical Center

Associate Professor of Medicine

UCSD, La Jolla, CA

Kevin Kwaku, MD, PhD, FACC

Chief, Division of Cardiology

Director, Cardiac Electrophysiology

Kaiser Permanente, Honolulu, HI

Norman Lepor, MD, FACC, FAHA, FSCAI

Governor, Southern California Chapter, ACC

Medical Director, Medical Education Outreach

Programs in the Division of Cardiology

Cedars Sinai Medical Center, Los Angeles, CA

Jonathan Lowy, MD

Medical Director, North Cascade Cardiology

Electrophysiologist

Peace Health-Southwest Medical Center

Bellingham, WA

Atul Malhotra, MD

Professor of Medicine

Division Chief, Pulmonary and Critical Care

Director of Sleep Medicine

UCSD, La Jolla, CA

Hirsch Mehta, MD, FACC

Cardiologist

San Diego Cardiac Center

Sharp Memorial Hospital, San Diego, CA

Michael Panutich, MD, FACC

Electrophysiologist

Newport Heart Medical Group

Newport Beach, CA

Kenneth Rosenfield, MD, FACC

Section Head, Vascular Medicine and Intervention

Massachusetts General Hospital

Boston, MA

Peter Schneider, MD

Vascular Surgeon

Chief, Vascular Surgery Division

Kaiser Permanente, Honolulu, HI

Navin Sawhney, MD, FACC

Electrophysiologist

Arch Health Partners

Escondido CA

Kalyanam Shivkumar, MD, PhD, FACC, FHRS

Professor of Medicine, Radiology & Bioengineering

Director, UCLA Cardiac Arrhythmia Center and EP

Programs; Interventional Cardiovascular Programs

Los Angeles, CA

Christian Spies, MD, FACC

Director of the Cardiac Catheterization Laboratory

Queen’s Medical Center

Honolulu, HI

Richard Wright, MD, FACC

Research Director and Director of the Heart Failure

Center, Pacific Heart Institute

Santa Monica, CA

Maui Cardiovascular Symposium October 12-14, 2017

PRESENTED BY

John B. Gordon III, M.D., F.A.C.C. Course Director

ENDORSED BY:

Hawaii and California Chapters American College Of Cardiology

Hawaii

CME provided by: San Diego Cardiac Center

Sponsored by: Sharp HealthCare Foundation and Rosa Azus Fund

Reg

iste

r o

nli

ne t

od

ay

:

http

s://w

ww

.eve

ntbr

ite.c

om/e

/201

7-an

nual

-mau

i-

card

iova

scul

ar-s

ympo

sium

-tic

kets

-316

4100

9110

Tu

itio

n:

$3

00

or

$1

40

sin

gle

day

San

Die

go M

edic

al P

rogra

m

31

31

Ber

ger

Aven

ue,

Suit

e 2

50

San

Die

go,

CA

92123

Ho

tel

Acco

mm

od

atio

ns

at

Sy

mp

osi

um

Rate

un

til

the

roo

m b

lock

fil

ls– F

air

mo

nt

Kea

Lan

i: 8

08

-87

5-2

25

0

Lo

cati

on

: F

air

mo

nt

Kea

Lan

i M

au

i,

41

00 W

ail

ea

Ala

nu

i D

r.,

Wail

ea,

HI

96

75

3

Via

em

ail:

https://aw

s.passkey.com/go/m

auicardiovascularsym

posium

Ru

n-O

f-O

cea

n V

iew

: $

41

5.0

0/n

igh

t p

lus

tax

Ru

n-O

f-N

on

-Vie

w:

$3

49

.00

/ n

igh

t p

lus

tax

A d

ep

osi

t fo

r tw

o n

igh

ts w

ill

be

taken

at

tim

e o

f re

serv

ati

on

.

Fo

r p

rog

ram

an

d s

po

nso

rsh

ip i

nfo

rmat

ion

co

nta

ct:

P

am

at

pk

uh

ns2

2@

aol.

com

or

97

9-2

19

-37

10

ACCREDITATION

This activity has been planned and implemented in accordance with the Institute

for Medical Quality and the California Medical Association’s CME Accreditation

Standards (IMQ/CMA) through the Joint Sponsorship of the San Diego Cardiac

Center and the San Diego Medical Program. The San Diego Cardiac Center is

accredited by the Institute for Medical Quality/California Medical Association

(IMQ/CMA) to provide continuing medical education for physicians. The San Diego

Cardiac Center takes responsibility for the content, quality and scientific integrity of

this CME activity.

AGENDA

THURSDAY, OCTOBER 12, 2017

12:00-1:00 PM Registration Pikake Foyer

FRIDAY, OCTOBER 13, 2017

The San Diego Cardiac Center designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit

1:00 -1:10 PM Aloha and Introductory Remarks John Gordon, MD

commensurate with the extent of their participation in the activity. This credit may

also be applied to the CMA Certification in Continuing Medical Education. 1:10 – 1:15 PM

Welcome from the Hawaiian Chapter ACC Kevin Kwaku, MD

DISCLOSURE STATEMENT As a provider of the IMQ/CMA, the San Diego Cardiac Center requires itself, staff,

affiliated physicians, individual contributors, faculty and planning committees

to disclose to attendees that the individual either has No Relevant Financial

Relationship(s) or has Relevant Financial Relationship(s), and to include the name of

the individual, name of commercial interest and nature of relationship. Disclosures will

be made to all participants prior to the educational activity commencement.

TARGET AUDIENCE Cardiologists, electrophysiologists, cardiovascular surgeons, interventional

radiologists, and other healthcare professionals with an interest in the treatment of

cardiovascular diseases.

SATURDAY, OCTOBER 14, 2017

2017 LEARNING OBJECTIVES On completion of this CME activity, participants should be able to:

• Differentiate recent interventional, pharmacological, device based surgical advances in the

treatment and management of sleep disordered breathing, cardiac arrhythmias, advanced

heart failure and cardiogenic shock, peripheral arterial disease, pulmonary hypertension

and acute pulmonary embolism.

• Recognize new medications and imaging modalities in the screening and management

of chest pain, coronary artery disease and hyperlipidemia.

• Define evolving role of the cardiologist in the treatment of diabetes.

• Differentiate recent advances in medical, surgical and percutaneous treatment for

management of hypertension, valvular heart disease, vascular disease, Kawasaki and

Takotsubo disease.

FRIDAY, OCTOBER 13, 2017

1:15-2:00 PM DEBATE: All implanted devices should be MRI compatible Charles Athill, MD

Kevin Kwaku, MD

2:00-2:30 PM New Tools for the Management of Cardiogenic Shock Brian Jaski, MD

2:30-3:00 PM The Evolving Role of the Cardiologist in the Treatment of Diabetes

Matthew Budoff, MD

3:00 - 3:30 PM Pulmonary Embolism and Deep Vein Thrombosis: New Approach to an Old Problem

Kenneth Rosenfield, MD

3:30-3:45 PM DISCUSSION / Break / EXHIBITS Hibiscus Room

3:45-4:15 PM The Journey of ACC-NCDR in Assuring FDA’s Mission of Safety and Effectiveness of Medical Devices: Focus on the STS / ACC TVT Registry

Ralph Brindis, MD

4:15-5:00 PM

DEBATE: Can transcatheter mitral repair be as good as direct surgical mitral valve repair?

Christian Spies, MD Robert Adamson, MD

5:00-6:30 PM Reception Royal Fountain Terrace

10:00-10:15 AM

DISCUSSION / Break / EXHIBITS

Hibiscus Room

10:15-11:00 AM DEBATE: TAVR is standard of care for the majority of

patients with severe aortic stenosis

Christian Spies, MD

Robert Adamson, MD

11:00-11:40 AM

Coronary PCI DEBATE: DES vs BVS

Tim Henry, MD John Gordon, MD

11:40 – 12:10 PM

1:00 – 5:00 PM

Modifying Ventricular Fibrillation by Targeted Rotor

Substrate Ablation

Coronary and Vascular Disease Workshops

David Krummen, MD

Robert Adamson, MD

John Gordon, MD

6:30-9:30 PM

Great Cases: Heart Failure Interventions

7:00-8:00 AM

Continental Breakfast

Hibiscus Room

8:00-8:05 AM

Welcome and Announcements

John Gordon, MD

8:05-8:35 AM

Advanced Cardiac Imaging

Robert Gillespie, MD

8:35-9:15 AM

Update 2017: Management of Aneurysmal Disease of the Aorta

Peter Schneider, MD

9:15-9:45 AM Cardiovascular Complications of Sleep Disorders

Atul Malhotra, MD

9:45- 10:15 AM

Femoral/Popliteal Disease: Challenges and Controversies

Kenneth Rosenfield, MD

10:15-10:30 AM

DISCUSSION / Break / EXHIBITS Hibiscus Room

10:30-11:00 AM

Pulmonary Hypertension in 2017: New Strategies

Hirsch Mehta, MD

11:00-11:30 AM Update Kawasaki Disease

Jane Burns, MD John Gordon, MD

11:30-12:00 PM Update: Takotsubo Dipti Itchhaporia, MD

1:00-5:00 PM

5:00-5:10 PM

Arrhythmia Management Workshops

Concluding Remarks

Charles Athill, MD

Kevin Kwaku, MD

John Gordon, MD

7:00-8:00 AM

Continental Breakfast

Hibiscus Room

7:30-7:35 AM

Welcome and Announcements

John Gordon, MD

7:35-8:20 AM DEBATE: NOACs should be the preferred option for all patients with A-fib who have risk factors for stroke

Richard Wright, MD Navin Sawhney, MD

8:20-8:50 AM Management of VT-Workup and Definitive Therapy

Kalyanam Shivkumar, MD

8:50-9:30 AM DEBATE: Is it time for Subcutaneous Implantable Defibrillators (SICD)?

Jonathan Lowy, MD

Michael Panutich, MD

9:30-10:00 AM Update on PCSK9 Inhibition – Do the outcome results meet

our expectations? Norman Lepor, MD